Disclosure 0000907654-26-000075-5

SEC FORM 4

$135,201.13

Oruka Therapeutics, Inc. (ORKA)

Sale of 1,268 shares at $106.6255 per share.

Reporting Person Agarwal Arjun · Officer Title Senior Vice President, Finance · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0000907654-26-000075 · filed 2026-08-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Oruka Therapeutics, Inc. (ORKA)." Disclosed 2026-08-14. https://desqlong.com/cards/0000907654-26-000075-5 (retrieved 2026-09-26).